Status:
COMPLETED
Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)
Lead Sponsor:
University of Florence
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
Brief Summary
Pulmonary infections are the major cause of mortality and morbidity in cystic fibrosis (CF); patients frequently have to take antibiotics which often cannot be given orally or by aerosol but have to b...
Detailed Description
To be included in the study, subjects need to fulfil the following requirements: * Diagnosis of CF, made accordingly to the CF Foundation Guideline; * Ability to consciously express owns informed con...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of CF, made accordingly to the CF Foundation Guideline
- Ability to consciously express owns informed consent, if aged 18 or more. If minor, presence of at least one legally authorised parent able to consciously express informed consent
- Have a TIVAD implanted
- Have no current complications in the TIVAD (infection, thromboembolic complications or occlusion)
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00670579
Start Date
May 1 2008
End Date
September 1 2010
Last Update
August 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cystic Fibrosis Center of Tuscany, Meyer Hospital
Florence, Tuscany, Italy